935248-17-2

Upstream product

• 62803-47-8 6-hydroxy-1-indanone 
• 13623-25-1 6-methoxy-2,3-dihydro-1H-inden-1-one 
• 935248-16-1 6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-one 

Downstream Products

• 935248-19-4 di-t-butyl {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-malonate 
• 935248-18-3 2-[{6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-(2-hydroxy-ethyl)-amino]-ethanol 
• 935248-22-9 3-[3-(2-chloro-ethyl)-indan-5-yloxymethyl]-5-(4-chloro-phenyl)-[1,2,4]oxadiazole 
• 935248-40-1 3-{6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-propionaldehyde 
• 935248-21-8 {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-ethanol 
• 935248-23-0 {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-propionitrile 
• 935248-20-7 {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-acetic acid 

Relevant academic research and scientific papers

A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening

The synthesis and structure-activity relationships (SAR) of a series of indane and tetralin inhibitors of the type 1 glycine transporter, derived from a high-throughput screening (HTS) hit, are described. Key modifications that reduced the 5HT1B receptor